In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 1.4 below Nephros Inc average.

Within Medical Equipment & Supplies industry 98 other companies have achieved higher Quick Ratio than Nephros Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1342 to 1531.

Explain Quick Ratio?
How much Cash & cash equivalents NEPH�s has?
What are NEPH�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NEPH Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	88.71 %	66.47 %	77.14 %	133.18 %	-9.22 %
Y / Y Cash & cash equivalent Change	-7.43 %	-1.54 %	43.62 %	110.46 %	64.74 %
Quick Ratio MRQ	1.4	1.59	1.95	2.1	2.86
NEPH's Total Ranking	# 1531	# 1342	# 743	# 920	# 727
Seq. Current Liabilities Change	32.33 %	-8.67 %	12.16 %	39.22 %	16.73 %
Seq. Cash & cash equivalent Change	16.9 %	-25.59 %	4.43 %	1.91 %	24.33 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 99
Healthcare Sector	# 575
Overall Market	# 1531

Quick Ratio Statistics
High	Average	Low
8.31	1.94	0.02
(Dec 31 2020)		(Dec 31 2012)

Financial Statements
Nephros Inc 's Current Liabilities	$ 3 Millions	Visit NEPH's Balance sheet
Nephros Inc 's Cash & cash equivalent	$ 5 Millions	Visit NEPH's Balance sheet
Source of NEPH's Sales		Visit NEPH's Sales by Geography

Cumulative Nephros Inc 's Quick Ratio

NEPH's Quick Ratio for the trailling 12 Months

NEPH Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	87.9 %	56.54 %	31.12 %	10.79 %	-16.35 %
Y / Y Cash & cash equivalent TTM Growth	25.46 %	46.98 %	52.56 %	34.2 %	-1.73 %
Quick Ratio TTM	1.74	2.06	2.31	2.47	2.6
Total Ranking TTM	# 3893	# 3078	# 2190	# 2826	# 2779
Seq. Current Liabilities TTM Growth	16.49 %	11.84 %	16.46 %	23.84 %	-2.96 %
Seq. Cash & cash equivalent TTM Growth	-1.92 %	-0.32 %	9.07 %	17.66 %	14.91 %

Quick ratio ranking by company, industry and sector >> Back to NEPH Financial Strength Comparisons >> Go to Compare NEPH Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q2 2026 to $3.34 millions, cumulative Quick Ratio decreased to 1.74 below the Nephros Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 199 other companies have achieved higher Quick Ratio than Nephros Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3078 to 3893.

Explain Quick Ratio?
How much Cash & cash equivalents NEPH�s has?
What are NEPH�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 200
Healthcare Sector	# 885
Within the Market	# 3893

trailing twelve months Quick Ratio Statistics
High	Average	Low
3.95	1.89	0.38
(Dec 31 2021)		(Sep 30 2017)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Irhythm Holdings Inc	3.82	$ 839.951 Millions	$ 219.981 Millions
Nutriband Inc	3.77	$ 3.422 Millions	$ 0.907 Millions
Logicmark Inc	3.71	$ 6.596 Millions	$ 1.779 Millions
Axogen inc	3.67	$ 111.412 Millions	$ 30.374 Millions
Procept Biorobotics Corporation	3.60	$ 230.952 Millions	$ 64.196 Millions
Heartbeam Inc	3.54	$ 8.700 Millions	$ 2.460 Millions
Mimedx Group Inc	3.53	$ 135.839 Millions	$ 38.498 Millions
Sensus Healthcare Inc	3.51	$ 15.186 Millions	$ 4.327 Millions
Outset Medical Inc	3.35	$ 147.194 Millions	$ 43.891 Millions
Inspiremd Inc	3.15	$ 30.421 Millions	$ 9.646 Millions
Fractyl Health Inc	3.00	$ 47.140 Millions	$ 15.736 Millions
Vivani Medical Inc	2.99	$ 19.894 Millions	$ 6.659 Millions
Retractable Technologies Inc	2.98	$ 39.870 Millions	$ 13.365 Millions
Neuropace Inc	2.97	$ 51.700 Millions	$ 17.433 Millions
Apyx Medical Corp	2.95	$ 27.617 Millions	$ 9.354 Millions
Omada Health Inc	2.94	$ 221.712 Millions	$ 75.483 Millions
Clearpoint Neuro Inc	2.85	$ 29.363 Millions	$ 10.313 Millions
Penumbra Inc	2.82	$ 658.795 Millions	$ 233.776 Millions
Glaukos Corp	2.80	$ 286.594 Millions	$ 102.329 Millions
Pulmonx Corporation	2.76	$ 56.393 Millions	$ 20.405 Millions
Intuitive Surgical Inc	2.71	$ 5,216.200 Millions	$ 1,922.900 Millions
Neuraxis Inc	2.69	$ 8.342 Millions	$ 3.096 Millions
Edwards Lifesciences Corporation	2.68	$ 4,291.700 Millions	$ 1,604.100 Millions
Modular Medical Inc	2.63	$ 3.920 Millions	$ 1.489 Millions
Co diagnostics Inc	2.55	$ 7.299 Millions	$ 2.863 Millions
Staar Surgical Co	2.47	$ 181.489 Millions	$ 73.394 Millions
Electromed Inc	2.35	$ 20.450 Millions	$ 8.714 Millions
EBR Systems, Inc.	2.18	$ 113.533 Millions	$ 52.023 Millions
Medinotec Inc	2.15	$ 2.519 Millions	$ 1.171 Millions
Atricure Inc	2.05	$ 167.786 Millions	$ 81.916 Millions

Date modified: 2026-09-12T06:14:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.